A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/07/2006	US7132112 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction
11/07/2006	US7132108 Immunizing poultry from infection from Salmonella enteritidis by administering a total dose of killed S. enteritidis of 0.15 to 15 mg, administered as a single dose, of a suspension of microspheres comprising killed S. enteritidis encapsulated in porous poly(lactide-coglycolide) copolymer shell
11/07/2006	US7132100 Palivizumab formulation comprising in aqueous carrier at least 40 mg/ml of palivizumab, or an antigen-binding fragment thereof and histidine, wherein formulation is free of surfactants and inorganic salts; for preventing or treating symptoms associated with a respiratory syncytial virus infection
11/07/2006	CA2375093C Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/07/2006	CA2301176C Self-binding shearform compositions
11/07/2006	CA2281755C Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/07/2006	CA2277824C Dosage composition for nasal delivery and method of use of the same
11/07/2006	CA2261988C Mannose-6-phosphate composition and its use in treating fibrotic disorders
11/07/2006	CA2251472C Material for buffered resorbable internal fixation devices and method for making same
11/02/2006	WO2006116742A2 Fluorescent nanoparticles conjugated to antibodies via a peg linker
11/02/2006	WO2006116628A2 Enzymes conjugated to antiobodies via a peg heterobifuctional linker
11/02/2006	WO2006116302A2 High-potency botulinum toxin formulations
11/02/2006	WO2006116156A2 Toxin peptides with extended blood halflife
11/02/2006	WO2006116107A2 Immunoliposome composition for targeting to a her2 cell receptor
11/02/2006	WO2006116076A2 Tab molecules
11/02/2006	WO2006115463A1 Pharmaceutical dosage forms comprising a lipid phase
11/02/2006	WO2006115416A2 Liposomes
11/02/2006	WO2006115293A1 NOVEL BLOCK COPOLYMER USED FOR PREPARING pH-RESPONSIVE POLYMER MICELLE, AND METHOD FOR PRODUCING SAME
11/02/2006	WO2006115285A1 Pharmaceutical composition
11/02/2006	WO2006115198A1 Porous cellulose aggregate and molding composition thereof
11/02/2006	WO2006115155A1 Liposome-containing preparation and process for producing the same
11/02/2006	WO2006114868A1 Medicinal preparation for percutaneous absorption
11/02/2006	WO2006114528A1 Method of preparing grafted polylysine dendrimers
11/02/2006	WO2006089993A3 Method of obtaining hydrogels of cyclodextrins with glycidyl ethers, compositions thus obtained and applications thereof
11/02/2006	WO2006072613A3 Preparation comprising microparticles of an insoluble polysaccharide resin with a biopolymeric active ingredient and method for production thereof
11/02/2006	WO2006065870A8 Topical numbing composition for laser therapy
11/02/2006	WO2006051110A3 Stable formulations of insulinoptropic peptides
11/02/2006	WO2005086641A3 Anti-infectious hydrogel compositions
11/02/2006	WO2005079396A3 O,o'-amidomalonate and n,o-amidomalonate platinum complexes
11/02/2006	WO2005067517A3 Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
11/02/2006	US20060247456 Reaction product of fatty acid in basic aqueous solution with alkali earth metal sulfate (magnesium sulfate, calcium sulfate)
11/02/2006	US20060247429 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability
11/02/2006	US20060247428 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
11/02/2006	US20060247426 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
11/02/2006	US20060247422 Chemically modified G-CSF
11/02/2006	US20060247306 Radiation protection by gamma-tocotrienol
11/02/2006	US20060247214 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
11/02/2006	US20060247203 Freeze-dried preparation containing methylcobalamin and process for producing the same
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247184 Treatment and prophylaxis of diseases and infections pigs and poultry
11/02/2006	US20060247183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
11/02/2006	US20060247177 Gonadotropin releasing hormone analogues conjugates with steroid hormones
11/02/2006	US20060246140 Method for the preparation of molecular complexes
11/02/2006	US20060246116 Formula and method for the delivery of medications to animals
11/02/2006	US20060246114 Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen
11/02/2006	US20060246060 Novel stable formulation
11/02/2006	US20060246053 Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or "novel acting thrombolytic agent" (NAT) with buffer of sodium citrate, zinc acetate, and/or calcium acetate; regeneration
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246034 Interferon-beta composite
11/02/2006	US20060246028 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	EP1717246A1 Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
11/02/2006	EP1716868A1 Anti-inflammatory analgesic for external use
11/02/2006	EP1716865A1 Paraoxonase-containing pharmaceutical preparation
11/02/2006	EP1716864A1 Neural regeneration using home bone morphogenetic proteins
11/02/2006	EP1716855A1 Remedy for external use for skin and mucosal injuries caused by viral infection
11/02/2006	EP1716846A2 Preparation and use of hydrogels
11/02/2006	EP1716845A1 Formulation of 5-aminolevulinic acid for dermal application
11/02/2006	EP1716234A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals
11/02/2006	EP1715895A2 Chemically-modified human growth hormone receptor antagonist conjugates
11/02/2006	EP1715894A2 Stable gabapentin compositions
11/02/2006	EP1715893A2 Direct compression formulation and process
11/02/2006	EP1715887A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
11/02/2006	EP1715884A1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
11/02/2006	EP1715871A1 Kinase inhibitor phosphonate conjugates
11/02/2006	EP1715861A2 Compositions comprising prodrugs of proton pump inhibitors
11/02/2006	EP1715854A2 Prodrugs for the intravenous administration of proton pump inhibitors
11/02/2006	EP1715851A1 Consumer customized dosage forms
11/02/2006	EP1715848A1 Microemulsion formulations comprising particular substance p antagonists
11/02/2006	EP1715846A2 Dissolvable film and method of manufacture
11/02/2006	EP1715845A2 Dissolvable film comprising an active ingredient and method of manufacture
11/02/2006	EP1517682B1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
11/02/2006	EP1474172B1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/02/2006	EP1337266A4 Mineralized collagen-polysaccharide matrix for bone and cartilage repair
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1284716B1 Self-emulsifying active substance formulation and use of this formulation
11/02/2006	EP1229867B1 Ophthalmologic implant
11/02/2006	EP1222930B1 Compositions for electroporation
11/02/2006	EP0877603B1 Methods and compositions for enhancing the bioadhesive properties of polymers
11/02/2006	DE102005018465A1 Bindemittel für Tabletten mit hoher Festigkeit auf Basis von Herstellung und Verwendung von feinteiligen Vinyllactampolymerenn, deren Herstellung und Verwendung Binders for tablets with high strength based on production and use of fine-particle Vinyllactampolymerenn, their preparation and use
11/02/2006	CA2609702A1 Antibody conjugates via heterobifunctional peg linkers
11/02/2006	CA2607738A1 Pharmaceutical dosage forms comprising a lipid phase
11/02/2006	CA2607455A1 Antibodies with immune effector activity and that internalize in endosialin-positive cells
11/02/2006	CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
11/02/2006	CA2606240A1 Method of preparing grafted polylysine dendrimers
11/02/2006	CA2606018A1 Nanoparticle conjugates
11/02/2006	CA2605560A1 Immunoliposome composition for targeting to a her2 cell receptor
11/02/2006	CA2605000A1 Biodegradable peptide sustained release compositions containing porogens
11/02/2006	CA2604999A1 Toxin peptides with extended blood halflife
11/01/2006	CN1856507A Method of stabilizing antibody and stabilized solution-type antibody preparation
11/01/2006	CN1856328A Tablet quickly disintegrating in oral cavity
11/01/2006	CN1856321A Use of calcitonin in osteoarthritis
11/01/2006	CN1856298A Tablet quickly disintegrating in oral cavity
11/01/2006	CN1854120A Non-toxic ion liquid its production and use
11/01/2006	CN1853732A Matrix metalloproteinase inhibitors as target component in diagnose agent
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1853729A Preparation of polynuclear iron hydroxide-sugar composite

1 ... 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 ... 1712